Abstract | OBJECTIVE: The purpose of the present study was to explore the expression and clinical significance of multiple tumor suppressor gene 1 (MTS1) and cyclooxygenase-2 (COX-2) gene in invasive breast cancers. METHODS: Flow cytometry was used to analyze the expression level of MTS1 and COX-2 in cancer tissues and corresponding para- cancer tissues from 66 cases of primary invasive breast cancers. RESULTS: In breast cancer tissues, the expression of MTS1 and COX-2 assessed by relative fluorescence intensity were 0.84 and 10.54, respectively, and were 1.61 and 4.00 in corresponding para- cancer tissues, respectively. There was a significant difference between MTS1 and COX-2 expressions in cancer and corresponding para- cancer tissues (P <0.05). The differences of MTS1 and COX-2 expression of different ages, pathological types, tumor sizes or clinical stages of the breast cancer patients were not significant (P > 0.05). The MTS1 and COX-2 expressions were 1.12 and 5.94, respectively, in lymph node metastasis positive patients, and 0.79 and 13.05, respectively, in lymph node metastasis negative patients. The differences were significant (P <0.05). CONCLUSION: The preliminary research results suggest that MTS1 and COX-2 gene expressions play fairly important role in tumorigenesis and progression of breast cancers. MTS1 and COX-2 protein expressions have correlation with lymph node metastasis. This study provides theoretical basis for use of COX-2 selective inhibitors in prevention and treatment for breast cancer patients.
|
Authors | Wen-shu Zuo, Ling Wei, Xing-Wu Wang, Yong-Sheng Wang, Zhi-Yong Yu, Ye Bi, Yan-Song Liu, Zheng-Bo Zhou |
Journal | Zhonghua zhong liu za zhi [Chinese journal of oncology]
(Zhonghua Zhong Liu Za Zhi)
Vol. 28
Issue 7
Pg. 515-7
(Jul 2006)
ISSN: 0253-3766 [Print] China |
PMID | 17147116
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
- Biomarkers, Tumor
- Cyclin-Dependent Kinase Inhibitor p16
- Cyclooxygenase 2
|
Topics |
- Adult
- Aged
- Biomarkers, Tumor
(metabolism)
- Breast
(metabolism, pathology)
- Breast Neoplasms
(metabolism, pathology)
- Carcinoma, Ductal, Breast
(metabolism, pathology)
- Cyclin-Dependent Kinase Inhibitor p16
(metabolism)
- Cyclooxygenase 2
(metabolism)
- Female
- Flow Cytometry
- Humans
- Lymphatic Metastasis
- Middle Aged
- Neoplasm Staging
|